ResMed   Report issue

For profit
Founded: San Diego CA United States (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2009
NCT00888342
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ResMed

Active Ingredients

Drugs in Other Trials (4)

ethanol (1 trial)

mva (1 trial)

oxygen (1 trial)

zopiclone (Zimovane) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 4